OKLO

NuScale Power is exploring industrial heat applications for its small modular reactors, with a 12-module plant potentially delivering 3 gigawatts of thermal energy and cutting chemical plant CO2 emissions by 80%-90%. The company is developing steam compression technology to expand industrial applications.

However, commercial adoption remains uncertain as NuScale must demonstrate systems at scale, secure customers, and arrange financing. Other nuclear developers like NANO Nuclear Energy and Oklo are pursuing similar strategies.

Cathie Wood's Ark Invest added to positions in Netflix, Oklo, and Intuitive Surgical on Wednesday, all of which have declined significantly over the past year. Netflix hit a two-year low after disappointing guidance, Oklo has surrendered 86% from its peak despite promising nuclear technology, and Intuitive Surgical faces competitive threats but maintains strong earnings beats.

Oklo and X-Energy are next-generation nuclear reactor companies capitalizing on growing energy demand. Oklo trades at a premium valuation (100x 2028 sales) due to earlier commercial deployment plans starting in 2027, while X-Energy appears undervalued (2.5x 2028 sales) despite a slower timeline to first deployments in the early 2030s. The analyst recommends X-Energy as the better value despite Oklo's near-term advantages.

Oklo (OKLO) stock has plummeted 55% this year and hit a new 52-week low of $31, despite potential growth opportunities in AI data center power solutions. However, the company faces significant challenges: it won't generate meaningful revenue until late 2025 when its Aurora facility begins operations, operating losses have more than doubled to $124.2 million in the first half of 2026, and its $6 billion valuation remains high for an early-stage company. Analysts suggest the stock remains too risky for most investors and could fall further.

Oklo is developing small nuclear reactors to power AI data centers and reduce fossil fuel dependence. While the company has secured support from Meta and other tech companies, it remains highly speculative with no commercial reactors deployed yet. For investors to become millionaires, the stock would need to gain 100-fold, making it an unrealistic expectation given the company's current stage and regulatory hurdles.

Oklo Inc. (OKLO) achieved first criticality at its Groves-1 Isotope Test Reactor in Texas in August 2026, following DOE startup authorization in July. The facility completed substantial construction in 229 days and secured enriched ytterbium-176 for cancer-treatment isotope production.

The company plans to leverage this experience for future isotope facilities while its Idaho lab may generate earlier revenues. However, OKLO shares have declined over 80% in the past year and carry a Zacks Rank #4 (Sell) rating.

The nuclear power sector is experiencing a renaissance driven by AI and electric vehicle demand. While high-risk upstarts like Oklo and NuScale offer cutting-edge technology, they are unprofitable with minimal revenue. Safer alternatives include dividend stocks: Constellation Energy (high growth, low yield), NextEra Energy (balanced growth and income), and Brookfield Renewable (high yield with diversified clean energy assets).

The article analyzes four nuclear reactor stocks and their potential valuations by 2031. Oklo, NuScale Power, and Nano Nuclear Energy face significant execution risks with current stock prices appearing to price in substantial post-2031 growth. BWX Technologies, a more established supplier with existing revenue, carries less commercialization risk but trades at a premium valuation with limited upside room.

Oklo is developing small sodium-cooled nuclear reactors aimed at providing clean, around-the-clock power. While the company has a talented leadership team and agreements with AI infrastructure companies, a preprint study suggests small modular reactors face significant profitability challenges due to high operating costs that could offset savings from cheaper construction. The article concludes Oklo remains highly speculative with no guarantee of success.

Oklo Inc. (OKLO) shares have declined 76.5% over the past year as investors grow concerned about mounting near-term execution risks, widening losses, and rising capital requirements. The company increased its 2026 operating cash-use forecast to $120M-$150M and capital spending to $400M-$500M, while its first commercial Aurora powerhouse targets 2028. Despite a substantial $3 billion cash position and progress in fuel and isotope projects, regulatory hurdles, commercialization delays, and shareholder dilution remain significant risks.

Three nuclear energy stocks have fallen significantly from their highs due to market headwinds. NuScale and Oklo, which develop innovative small modular reactors, have plummeted 86% and 79% respectively but lack commercial deployment and trade at extremely high valuations. BWX Technologies, a more established and profitable nuclear supplier with defense contracts, has only pulled back 40% and offers a more balanced opportunity in the resurgent nuclear market.

Three publicly traded small modular reactor (SMR) companies are positioned to benefit from AI data center power demands. Oklo has the largest backlog (18.1 GW) but much is nonbinding; NuScale offers traditional utility-focused approach with 6-7 GW backlog concentrated with one customer; GE Vernova has the highest quality backlog with active construction projects but weakest SMR exposure at under 3% of sales.

Wall Street firms predict a nuclear energy renaissance driven by AI data center demand, which is expected to increase power consumption by 175% by 2030. Investors can gain exposure through three approaches: small modular reactor (SMR) developers like NuScale and Oklo, nuclear utility operators like Constellation Energy, or uranium ETFs.

BWX Technologies is positioned to outperform nuclear peers Oklo and NuScale through 2030 due to its established $3.2 billion revenue base and decades of nuclear manufacturing experience. While Oklo and NuScale are still commercializing reactor technologies, BWXT generates revenue from U.S. Navy contracts, TRISO fuel production, medical isotopes, and is developing advanced reactors and microreactors. The company raised its 2026 revenue guidance to $3.8 billion with 19% growth expected.

X-Energy, a small modular reactor (SMR) developer, went public at $23 per share in April 2026 but has since dropped to $14, trading 40% below its IPO price. While the company has secured major deals with Amazon and Dow, it faces significant challenges including unproven TRISO fuel technology, regulatory hurdles with the NRC, and a premium valuation at 19x sales despite ongoing losses. The analyst recommends avoiding X-Energy in favor of more established nuclear players like BWX Technologies.

Oklo Inc. is developing an Advanced Fuel Center in Oak Ridge, TN, to recycle spent nuclear fuel with potential $1.68B investment and 800+ jobs. The project could recover up to 95% of fuel energy from the U.S.'s 100,000 metric tons of stored used fuel.

However, commercial profitability remains unproven. Meanwhile, competitors like Entergy and NextEra Energy are pursuing traditional nuclear growth strategies focused on generation capacity and fuel supply rather than recycling.

Both Centrus Energy and BWX Technologies are positioned in the growing nuclear supply chain, benefiting from surging electricity demand from AI data centers and government support for nuclear energy. Centrus has declined 54% in 2026 as it undergoes capital-intensive expansion to become a domestic producer of enriched uranium fuel for advanced reactors. BWX Technologies has fallen 22% and maintains an exclusive, stable position as the sole supplier of weapons-grade nuclear fuel for the U.S. Navy with long-term contracts.

Centrus Energy is positioned as an attractive nuclear investment opportunity due to its dominant position as the only HALEU enricher in the Western World. With a $4.5 billion backlog of LEU and HALEU sales commitments and a $2.4 billion market cap, the company could potentially grow tenfold as advanced reactor makers scale operations, offering significant wealth-building potential without needing to build reactors itself.

Google and Constellation Energy signed a landmark 3.59 GW power purchase agreement worth $4.3 billion in nuclear upgrades, highlighting a structural renaissance in the nuclear industry driven by AI data center demand. The deal exemplifies a broader trend of tech hyperscalers securing long-term nuclear power contracts, reshaping valuations across the nuclear supply chain and making nuclear ETFs attractive investment vehicles.

Cameco's stock has fallen from $134 to $85 after initial investor enthusiasm for nuclear power waned. However, the article argues this presents an opportunity, as nuclear power is experiencing a genuine renaissance driven by surging electricity demand from AI and electric vehicles. With uranium supply expected to fall short of demand in the early 2030s and Cameco owning half of Westinghouse, the company is well-positioned to benefit from the nuclear comeback.